BSE filing, BSE: 535322. Summary written from the filing by ALFA Finder's alert engine.
Repco Home Finance Ltd: key numbers
- Share price
- ₹304.20
- Market cap
- ₹1,903 Cr
- Revenue (annual)
- ₹1,792 Cr
- Net profit (annual)
- ₹475.4 Cr
- P/E (TTM)
- 4.0×Sector 19.7×
- Promoter holding
- 37.13%+0.00% QoQ
- FII holding
- 11.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Repco Home Finance Ltd
All →Repco Home Finance Other Announcement
Crisil ESG Ratings assigned Repco Home Finance an ESG score of 64, categorised as strong. The rating was prepared independently using public information.
Repco Home Finance Debt & Borrowing: ₹0.86 Cr
Repco Home Finance Ltd has successfully paid interest amounting to Rs.0.86 Crore on its 8.40% debt securities for the period ending October 2026.
- Value
- ₹0.86 Cr
Repco Home Finance Other Announcement
Repco Home Finance filed a routine quarterly intimation under Reg 6(1) and 7(1) naming its Compliance Officer and RTA for debt securities. No transaction, money, or business decision is involved.
Repco Home Finance Management Change
Repco Home Finance appointed Rajagopal & Badri Narayanan as statutory auditor, alongside directors Aparna Sudip Kumar and Bakthavatsalu Kannan.
Repco Home Finance Debt & Borrowing: ₹2,500 Cr
Repco Home Finance Limited received shareholder approval at its AGM to raise Rs. 2,500 Crore through the issuance of Non-Convertible Debentures and Commercial Papers.
- Value
- ₹2,500 Cr
Repco Home Finance Other Announcement
Repco Home Finance appointed M/s. Rajagopal & Badri Narayanan as Joint Statutory Auditor for three years, approved at the 26th Annual General Meeting held recently.
- Execution
- 3 years
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.